GA CoV-2 IgG/IgM/IgG+ – ELISA kits for COVID-19 diagnostics
MEDIPAN GmbH
Our GA CoV-2 IgG/IgM/IgG+ ELISA kits are serological tests (Enzyme Immunoassays) to identify virus-specific SARS-CoV-2 antibodies in patients. They are ideally suited for screening and subsequent confirmation of the antibody status in patients, in order to verify the individual immune protection, control the existing pandemic and reduce the spread of SARS-CoV-2 through targeted measures. The GA CoV-2 IgG+ confirmatory test offers reliable support to differentiate other coronavirus infections and aids in the assessment of immune protection. Following a positive antibody result in screening, virus-specific antibodies against the N-, S1- and S2- proteins are determined using this confirmatory test. GA CoV-2 IgG / IgM ELISA screening for the determination of IgG or IgM SARS-CoV-2 antibodies 96 determinations 105 min total assay time CE GA CoV-2 IgG+ - IgG confirmatory test specific for SARS-CoV-2 N-, S1- and S2-proteins 24x4 determinations per test kit 105 min total assay time CE
Vorteile des Produkts
- Screening & Confirmation test available
- Virus-specific antibodies against the N-, S1- and S2- proteins
- CE marked